Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials. (2024). Journal of Kidney Cancer, 11(3), 51-58. https://doi.org/10.15586/jkcvhl.v11i3.352